- ROUNDTABLE: Pharmacy’s future in sync with technology
- Valeant approved for Retin-A Micro
- EXPERT BLOG: Provider status for pharmacists — one way or another
- New Rite Aid group VP pharmacy initiatives and clinical services to oversee Wellness Ambassador program
- NACDS, NCPA, GPhA express support for Drug Quality and Security Act
HYDERABAD, India — Dr. Reddy's has launched a drug for treating acne, the company said Friday.
The Indian generic drug maker announced the launch of Zenatane (isotretinoin) capsules in the 20-mg and 40-mg strengths. The drug is a therapeutically equivalent generic version of Roche's Accutane. The Food and Drug Administration also approved the drug in the 10-mg strength.
Various versions of the drug had sales of about $309 million during the 12-month period that ended in January, according to IMS Health.